Rib-X Pharmaceuticals To Present At 10th Annual Superbugs & Superdrugs Conference
Rib-X Pharmaceuticals, Inc. (”Rib-X” or the “Company”), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced that Albert Collinson, Ph.D., Chief Business Officer, will be presenting at the 10th Annual Superbugs & Superdrugs Conference on April 9, 2008 in London, UK. Dr.
More: continued here
Filed under: Clinical Trials on April 4th, 2008